The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in the culture

Annals of Oncology

Volumn 7, Issue 7, 1996, Pages 731-737

  Cwikiel, M ^a   Eskilsson, J ^a   Albertsson, M ^a   Stavenow, L ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 fluorouracil; Cardiotoxicity; Cell culture model; Endothelium; Prostacyclin

Indexed keywords

FLUOROURACIL; METHOTREXATE; PROSTACYCLIN;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG TOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0029810892     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010723     Document Type: Article

References (26)

1. Gradishar WJ, Vokes EE. 5-Fluorouracil cardiotoxicity: A critical review. Ann Oncol 1990; 1: 409-14.
2. Ensley JF, Patel B, Kloner R et al. The clinical syndrome of 5-fluorouracil cardiotoxicity. Invest New Drugs 1989; 7: 101-9.
3. Robben N, Pippas A, Moore J. The syndrome of 5-fluorouracil cardiotoxicity. Cancer 1993; 71 (2): 493-509.
4. Freeman N, Constanza M. 5-Fluorouracil-associated cardiotoxicity. Cancer 1988; 61: 36-45.
5. Burger AJ, Mannino S. 5-Fluorouracil induced coronary vasospasm. Am Heart J 1989; 114: 433-6.
6. Stevenson DL, Mikhailidis DP, Gillett DS. Cardiotoxicity of 5-fluorouracil. Lancet 1977; 2: 406-7 (Letter).
7. Kuzel T, Esyaraz B, Green D et al. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990; 65: 885-9.
8. Cwikiel M, Albertsson M, Zhang B et al. The influence of 5-fluorouracil on the endothelium in small arteries. A scanning and transmission electron microscopic study in rabbits. Scan Micros 1995; 9(2): 561-76.
9. Vane JR, Änggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
10. Nimmrich H, Meaires S, Forssman et al. Scanning electron microscopy of endothelium. In Didio LJT, Motta PM, Allen DJ (eds): Three Dimensional Microanatomy of Cells and Tissue Surfaces. Amsterdam: Elsevier 1981.
11. Mason R, Sharp D, Chuang H. The endothelium. Role in thrombosis and haemostasis. Arch Pathol Lab Med 1977; 101: 61.
12. Xu CB, Stavenow L, Pessah-Rasmussen H. Interactions between cultured bovine arterial endothelial and smooth muscle cells; studies on the release of prostacycline by endothelial cells. Artery 1992; 19(2): 94-111.
13. Wenzel DG, Cosma GN. A model system for measuring comparative toxicities of cardiotoxic drugs for cultured rat heart myocytes, endothelial cells and fibroblasts. II. Doxorubicin, 5-fluorouracil and cyclophosphamide. Toxicol 1984; 33: 117-28.
14. Hirata S, Matsubara T, Saura R et al. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularisation by low-dose methotrexate. Arthritis Rheum 1989; 32(2): 1065-73.
15. Schornagel JH, McVie. The clinical pharmacology of methotrexate. Cancer Treat Rev 1983; 10: 53-75.
16. Edelman J, Biggs DF, Jamali F et al. Low-dose methotrexate kinetics in arthritis. Clin Pharmacol Ther 1984; 35: 382-6.
17. Kremer JM, Galivan J, Streckfuss A et al. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 1986; 29: 832-5.
18. Findlay MPN, Raynaud F, Cunningham D et al. Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug level observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without interferone. Ann Oncol 1996; 7: 47-53.
19. Witte L, Kaplan K, Nossel H et al. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 1978; 42: 402-9.
20. Stavenow L, Falke P, Berglund A. Effects of different injurious stimuli on cell death, proliferation, and collagen secretion by rabbit aortic smooth muscle cells and human umbilical vein endothelial cells in culture. Med Biol 1983; 61: 214-8.
21. Lowry OH, Rosenbourg NJ, Farr AL et al. Protein measurements with folin phenol reagent. J Biol Chem 1951; 193: 265-75.
22. Falke P, Mattiasson I, Stavenow L et al. Effects of a competitive inhibitor (mevinolin) of 3-hydroxy-3-methylglutaryl coenzym A reductase on human and bovine endothelial cells, fibroblasts and smooth muscle cells in vitro. Pharmacol & Toxicol 1989; 64: 173-6.
23. Pessah-Rasmussen H, Stavenow L, Seidegård J-E et al. Human fibroblasts lacking trans-stilbene oxide active glutathione transferase exhibit increased cell death when exposed to polycyclic aromatic hydrocarbons. Pharmacol & Toxicol 1992; 70: 361-5.
24. Eckel RW, Fujimoto WY. Quantification of cell death in human fibroblasts by measuring the loss of 14C-thymidine from pre-labelled cell monolayers. Anal Biochem 1981; 114: 118-24.
25. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing factor VIII related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734-7.
26. Cwikiel M, Eskilsson J, Wieslander JB, Stjernquist U, Albertsson M. The appearance of endothelium in small arteries after the treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scanning Microsc 1996; 10(3): in press.